文献速递关节外科

多发性硬化患者行全关节置换术后的假体生存率与结局

Survivorship and Outcomes in Patients With Multiple Sclerosis Undergoing Total Joint Arthroplasty.
PubMed 文献 · J Arthroplasty · 2017-11-08

单机构2000至2016年回顾108例多发性硬化患者全关节置换(46膝、62髋),平均随访6.2年,19.4%需翻修,不稳(5.6%,P=0.0278)和假体周围感染(4.6%,P=0.0757)为常见原因;2、5、7年生存率分别为96.5%、86.3%、75.3%,功能改善幅度小于无多发性硬化患者。

要点

  • 多发性硬化患者全关节置换翻修率为19.4%(21/108),不稳(5.6%)和假体周围感染(4.6%)为常见翻修原因。
  • 2、5、7年假体生存率分别为96.5%、86.3%、75.3%。
  • 多发性硬化患者功能评分改善幅度小于无多发性硬化患者。

核心结论

  • 多发性硬化患者全关节置换并发症风险增加,尤其是不稳和假体周围感染。
  • 尽管并发症风险增加,多发性硬化患者功能结局仍可改善,但改善幅度不及无多发性硬化患者。
  • 多发性硬化患者在接受全关节置换前应接受适当咨询。

研究设计与样本

  • 单机构回顾性研究,纳入2000至2016年108例全关节置换(46膝和62髋),通过基于多发性硬化药物和国际疾病分类第九版编码的电子病历查询识别人群,并人工复核确认诊断。
  • 以任何原因翻修为主要终点,采用简表12评分评估功能结局,用Kaplan-Meier法生成生存曲线。

主要发现

  • 平均随访6.2年,19.4%(21/108)患者需翻修手术。
  • 翻修最常见原因包括不稳(5.6%,P=0.0278)和假体周围感染(4.6%,P=0.0757)。
  • 全关节置换总体生存率在2年、5年、7年分别为96.5%(95%CI 92.6-100)、86.3%(95%CI 77.7-94.5)、75.3%(95%CI 63.5-87.0)。
  • 多发性硬化队列功能评分改善小于无多发性硬化患者。

临床怎么用

  • 多发性硬化患者在接受全关节置换前应接受适当咨询。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with multiple sclerosis (MS) frequently require total joint arthroplasty (TJA). The outcomes of TJA in patients with MS, who are frequently on immunomodulatory medications and physically deconditioned, remain largely unknown. The aim of this study is to elucidate the survivorship and reasons for failure in this patient population. METHODS: A single-institution retrospective review of 108 TJAs (46 knees and 62 hips) was performed from 2000 to 2016. An electronic chart query based on MS medications and International Classification of Diseases, Ninth Revision codes was used to identify this population followed by a manual review to confirm the diagnosis. Outcomes were then assessed using revision for any reason as the primary end point. Functional outcomes were assessed using Short Form 12 scores. Survivorship curves were generated using the Kaplan-Meier method. RESULTS: At an average follow-up of 6.2 years, 19.4% (21/108) of patients required a revision surgery. Instability (5.6%, P = .0278) and periprosthetic joint infection (4.6%, P = .0757) were among the most common reasons for revision. The overall survivorship of TJA at years 2, 5, and 7, respectively, was 96.5% (95% confidence interval [CI], 92.6-100), 86.3% (95% CI, 77.7-94.5), and 75.3% (95% CI, 63.5-87.0). Functional score improvement was less in MS cohort than patients without MS. CONCLUSION: Patients with MS are at increased risk of complications, particularly instability and periprosthetic joint infection. Despite this increased risk of complications, patients with MS can demonstrate improved functional outcomes, but not as much as patients without MS. Patients with MS should be counseled appropriately before undergoing TJA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Rondon AJ, Schlitt PK, Tan TL, et al. Survivorship and Outcomes in Patients With Multiple Sclerosis Undergoing Total Joint Arthroplasty. J Arthroplasty. 2017. PMID: 29174408. doi:10.1016/j.arth.2017.10.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。